AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33615980 — intervention group
Group type: EXPERIMENTAL
Intervention: Age (b: 0.90; p: 0.021)
Number of subjects: 3094
Study 33615980 — intervention group
Group type: COMPARATOR
Intervention: Economic status (b: -21.1; p < .001)
Number of subjects: 3094
Study 33615980 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentration index (C)
Number of subjects: 3094
Study 33615980 — intervention group
Group type: EXPERIMENTAL
Intervention: ECSU in the poor
Number of subjects: 3094
Study 33615980 — intervention group
Group type: EXPERIMENTAL
Intervention: ECSU in the rich
Number of subjects: 3094
Study 33615980 — intervention group
Group type: EXPERIMENTAL
Intervention: Gap between rich and poor
Number of subjects: 3094
Study 33615980 — intervention group
Group type: EXPERIMENTAL
Intervention: Explained portion
Number of subjects: 3094
Study 33615980 — intervention group
Group type: EXPERIMENTAL
Intervention: Unexplained portion coefficient
Number of subjects: 3094
Study 32751269 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g OBG varying in MW and viscosity
Number of subjects: 16
Study 32751269 — intervention group
Group type: COMPARATOR
Intervention: Control (200 mL water alone)
Number of subjects: 16
Study 36057214 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegaderm™
Number of subjects: 0
Study 36057214 — intervention group
Group type: COMPARATOR
Intervention: No Tegaderm™
Number of subjects: 0
Study 33836004 — intervention group
Group type: EXPERIMENTAL
Intervention: Chikungunya virus (CHIKV) serology positive
Number of subjects: 377
Study 33836004 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms consistent with chikungunya
Number of subjects: 377
Study 35081272 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-rich diet
Number of subjects: 156
Study 35081272 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate-rich diet
Number of subjects: 156
Study 34333922 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacral magnetic stimulation (SMS) combined with bladder function training, awakening training, and life and psychological intervention
Number of subjects: 57
Study 34511588 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Z500 composite
Number of subjects: 12
Study 34511588 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Bulk Fill composite
Number of subjects: 12
Study 34511588 — intervention group
Group type: COMPARATOR
Intervention: Ketac Universal (high-viscosity glass ionomer cement)
Number of subjects: 12
Study 34511588 — intervention group
Group type: COMPARATOR
Intervention: Matrix systems (Tofflemire, AutoMatrix, matrix band with ring, contoured sectional matrix)
Number of subjects: 12
Study 35500594 — intervention group
Group type: EXPERIMENTAL
Intervention: Village doctor-led multifaceted intervention
Number of subjects: 33995
Study 35500594 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (control)
Number of subjects: 33995
Study 34098980 — intervention group
Group type: EXPERIMENTAL
Intervention: Opuntia ficus-indica juice (OFI)
Number of subjects: 8
Study 34098980 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 33089713 — intervention group
Group type: EXPERIMENTAL
Intervention: Active CO2-laser treatment
Number of subjects: 58
Study 33089713 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 58
Study 35643855 — intervention group
Group type: EXPERIMENTAL
Intervention: Inotuzumab ozogamicin (InO)
Number of subjects: 326
Study 35643855 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care chemotherapy (SoC)
Number of subjects: 326
Study 34616460 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 60
Study 34616460 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 60
Study 34616460 — intervention group
Group type: COMPARATOR
Intervention: Wait-List Group (WLG)
Number of subjects: 60
Study 34521609 — intervention group
Group type: EXPERIMENTAL
Intervention: Decitabine plus talacotuzumab
Number of subjects: 309
Study 34521609 — intervention group
Group type: COMPARATOR
Intervention: Decitabine alone
Number of subjects: 309
Study 32308631 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological online intervention (POI) with mindfulness module
Number of subjects: 55
Study 32308631 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 55
Study 32308631 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological online intervention (POI)
Number of subjects: 55
Study 36154981 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological mesh
Number of subjects: 24
Study 36154981 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic mesh
Number of subjects: 24
Study 34473420 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-supplementation of omega-3 and vitamin D
Number of subjects: 168
Study 34473420 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study 34473420 — intervention group
Group type: COMPARATOR
Intervention: Omega-3
Number of subjects: 168
Study 34473420 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D
Number of subjects: 168
Study 32659365 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompression with Interlaminar Stabilization (ILS)
Number of subjects: 141
Study 32659365 — intervention group
Group type: COMPARATOR
Intervention: Decompression with fusion
Number of subjects: 141
Study 32659365 — intervention group
Group type: COMPARATOR
Intervention: Decompression with Interlaminar Stabilization (ILS) in patients <age 65
Number of subjects: 141
Study 35027012 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (60% FiO2 and 0.1 µg/kg PGE1)
Number of subjects: 90
Study 35027012 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (40% FiO2 and 0.1 µg/kg PGE1)
Number of subjects: 90
Study 35027012 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (40% FiO2 and 0.2 µg/kg PGE1)
Number of subjects: 90
Study 35027012 — intervention group
Group type: COMPARATOR
Intervention: Control (no PGE1)
Number of subjects: 90
Study 32163923 — intervention group
Group type: EXPERIMENTAL
Intervention: Jump-Rope Training (2-4 sessions/week, 10-20 minutes/week for 10 weeks)
Number of subjects: 96
Study 32163923 — intervention group
Group type: COMPARATOR
Intervention: Control warm-up routine
Number of subjects: 96
Study 32734819 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco cigarette (TC) smoking
Number of subjects: 136
Study 32734819 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic cigarette with nicotine (ECN)
Number of subjects: 136
Study 32734819 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic cigarette without nicotine (EC0)
Number of subjects: 136
Study 32734819 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine inhaler (NI)
Number of subjects: 136
Study 32734819 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 136
Study 32734819 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline FMD
Number of subjects: 136
Study 36177851 — intervention group
Group type: EXPERIMENTAL
Intervention: pIONM (n=90)
Number of subjects: 189
Study 36177851 — intervention group
Group type: COMPARATOR
Intervention: Control (n=99)
Number of subjects: 189
Study 32559027 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (2.0 mg/kg, i.p.) in mice
Number of subjects: 70
Study 32559027 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (0.3 mg/kg, p.o.) in humans
Number of subjects: 70
Study 32559027 — intervention group
Group type: COMPARATOR
Intervention: Dextroamphetamine (0.3 mg/kg, p.o.)
Number of subjects: 70
Study 32559027 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine administration
Number of subjects: 70
Study 32559027 — intervention group
Group type: EXPERIMENTAL
Intervention: mGlu5 expression in drug-naïve mice
Number of subjects: 70
Study 32251932 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional development intervention program (with and without parental-awareness meetings)
Number of subjects: 444
Study 32251932 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 444
Study 35536828 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 120
Study 35536828 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 120
Study 35536828 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (Control)
Number of subjects: 120
Study 32692113 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral Therapy (ART)
Number of subjects: 333
Study 33094550 — intervention group
Group type: EXPERIMENTAL
Intervention: PROPESS (dinoprostone vaginal insert) for a maximum of 12 h
Number of subjects: 114
Study 33471681 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/day prednisone for 1 week followed by 1 week of nonsteroidal anti-inflammatory drugs
Number of subjects: 50
Study 33471681 — intervention group
Group type: COMPARATOR
Intervention: 6-week prednisone therapy
Number of subjects: 50
Study 33188874 — intervention group
Group type: EXPERIMENTAL
Intervention: Utidelone plus capecitabine (30 mg/m2 IV daily, days 1-5, over 90 min; capecitabine 1000 mg/m2 orally b.i.d., days 1-14)
Number of subjects: 405
Study 33188874 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine alone (1250 mg/m2 orally b.i.d., days 1-14)
Number of subjects: 405
Study 33188874 — intervention group
Group type: EXPERIMENTAL
Intervention: Utidelone plus capecitabine
Number of subjects: 405
Study 33188874 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine alone
Number of subjects: 405
Study 33129015 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal treatment + electrotherapy
Number of subjects: 101
Study 33129015 — intervention group
Group type: COMPARATOR
Intervention: Only hormonal treatment (control)
Number of subjects: 101
Study 35344064 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (Arciero technique)
Number of subjects: 19
Study 35344064 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (LaPrade technique)
Number of subjects: 19
Study 34931372 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyzetimibe (HS-25)
Number of subjects: 24
Study 32627803 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker support and home blood pressure monitoring
Number of subjects: 60
Study 32627803 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study 616279207 — intervention group
Group type: EXPERIMENTAL
Intervention: IFR-guided side-branch intervention group
Number of subjects: 50
Study 616279207 — intervention group
Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 50
Study 35858944 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional alignment (FA) surgical technique
Number of subjects: 240
Study 35858944 — intervention group
Group type: COMPARATOR
Intervention: Mechanical alignment (MA) surgical technique (control group)
Number of subjects: 240
Study 34197676 — intervention group
Group type: EXPERIMENTAL
Intervention: High fruit and vegetable diet
Number of subjects: 67
Study 34197676 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual diet)
Number of subjects: 67
Study 34625480 — intervention group
Group type: EXPERIMENTAL
Intervention: Singing for Lung Health (SLH) training
Number of subjects: 270
Study 34625480 — intervention group
Group type: COMPARATOR
Intervention: Standard physical exercise training (PExT)
Number of subjects: 270
Study 33941143 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive Glenohumeral Internal Rotation with Clam Shell Bridging
Number of subjects: 42
Study 33941143 — intervention group
Group type: COMPARATOR
Intervention: Modified sleeper stretching
Number of subjects: 42
Study 33941143 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Passive Glenohumeral Internal Rotation and Modified sleeper stretching)
Number of subjects: 42
Study 35691208 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for insomnia (CBTi) - 8 weekly group sessions over 3 months
Number of subjects: 62
Study 35691208 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 62
Study 34417205 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic conditioning (RIC) - 4 cycles of blood pressure cuff inflation to 200 mm Hg for 5 min of ischaemia followed by 5 min of reperfusion
Number of subjects: 252
Study 34417205 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic conditioning (RIC)
Number of subjects: 252
Study 34417205 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 252
Study 36306706 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Atkins diet (MAD)
Number of subjects: 101
Study 36306706 — intervention group
Group type: COMPARATOR
Intervention: Levetiracetam
Number of subjects: 101
Study 33925432 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron extract (15.5 mg per day)
Number of subjects: 66
Study 33925432 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 66
Study 32415458 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclosing a history of depression
Number of subjects: 596
Study 32415458 — intervention group
Group type: COMPARATOR
Intervention: Disclosing a history of diabetes
Number of subjects: 596
Study 32415458 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong applicants who disclosed depression
Number of subjects: 596
Study 32638243 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary closure of direct defect prior to mesh placement
Number of subjects: 53
Study 32638243 — intervention group
Group type: COMPARATOR
Intervention: Non-closure of direct defect prior to mesh placement
Number of subjects: 53
Study 35268056 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-Low-Calorie Ketogenic Diet (VLCKD)
Number of subjects: 100
Study 35268056 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean Diet (MedDiet)
Number of subjects: 100
Study 32929501 — intervention group
Group type: EXPERIMENTAL
Intervention: Watchman device implantation
Number of subjects: 5175
Study 34935229 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and support program tailored to barriers and facilitators for implementing alcohol SBIs (n=6 PHCPs, 110 participants)
Number of subjects: 222
Study 34935229 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and support program
Number of subjects: 222
Study 34935229 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control (n=6 PHCPs, 112 participants)
Number of subjects: 222
Study 32046994 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 0
Study 32046994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33185990 — intervention group
Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil (25 mg, 37.5 mg, or 50 mg twice daily)
Number of subjects: 8256
Study 33185990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8256
Study 33185990 — intervention group
Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil
Number of subjects: 8256
Study 32183741 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron (initially 25 mg/day, optional increase to 50 mg/day after week 4/8)
Number of subjects: 887
Study 32183741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 887
Study 35296780 — intervention group
Group type: EXPERIMENTAL
Intervention: VV116 (oral nucleoside analog)
Number of subjects: 86
Study 35296780 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 32639460 — intervention group
Group type: EXPERIMENTAL
Intervention: V114 Lot 1
Number of subjects: 1051
Study 32639460 — intervention group
Group type: EXPERIMENTAL
Intervention: V114 Lot 2
Number of subjects: 1051
Study 32639460 — intervention group
Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 1051
Study 35656740 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital divorce intervention
Number of subjects: 676
Study 35656740 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower neuroticism
Number of subjects: 676
Study 33737443 — intervention group
Group type: EXPERIMENTAL
Intervention: Epley manoeuvre (EM)
Number of subjects: 80
Study 33737443 — intervention group
Group type: COMPARATOR
Intervention: Sham manoeuvre
Number of subjects: 80
Study 36418539 — intervention group
Group type: EXPERIMENTAL
Intervention: Support underwear
Number of subjects: 50
Study 36418539 — intervention group
Group type: COMPARATOR
Intervention: Control group (no support underwear)
Number of subjects: 50
Study 34100746 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailor‐made notched music therapy
Number of subjects: 104
Study 34100746 — intervention group
Group type: COMPARATOR
Intervention: Ordinary music
Number of subjects: 104
Study 32029012 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice weekly sessions of CBT or IPT
Number of subjects: 200
Study 32029012 — intervention group
Group type: COMPARATOR
Intervention: Weekly sessions of CBT or IPT
Number of subjects: 200
Study 34905990 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Education and Relationship Training (HEART)
Number of subjects: 198
Study 34905990 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched control
Number of subjects: 198
Study 33581692 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum calcium levels
Number of subjects: 394929
Study 33581692 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum selenium levels
Number of subjects: 394929
Study 33581692 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum retinol levels
Number of subjects: 394929
Study 33581692 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E levels
Number of subjects: 394929
Study 33581692 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum retinol and vitamin E levels
Number of subjects: 394929
Study 33482395 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Automated Voice Reorientation (FAVoR) intervention over a 5-day period
Number of subjects: 178
Study 33482395 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 178
Study 33482395 — intervention group
Group type: EXPERIMENTAL
Intervention: FAVoR intervention
Number of subjects: 178
Study 34093551 — intervention group
Group type: EXPERIMENTAL
Intervention: Nexvax2 (900 μg, n = 12)
Number of subjects: 21
Study 34093551 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 9)
Number of subjects: 21
Study 34475136 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 vaccine
Number of subjects: 154
Study 34475136 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched health care workers)
Number of subjects: 154
Study 34475136 — intervention group
Group type: EXPERIMENTAL
Intervention: Both cohorts (patients and controls)
Number of subjects: 154
Study 34475136 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 154
Study 34475136 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient cohort
Number of subjects: 154
Study 32551868 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimum tension group (96.3 ± 4.9 N)
Number of subjects: 78
Study 32551868 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum tension group (199.0 ± 20.3 N)
Number of subjects: 78
Study 33502615 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital educational platform (DEP) + Standard verbal consent (SVC)
Number of subjects: 51
Study 33502615 — intervention group
Group type: COMPARATOR
Intervention: Standard verbal consent (SVC)
Number of subjects: 51
Study 34191140 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacterial cellulose (BC) wound dressing
Number of subjects: 39
Study 34191140 — intervention group
Group type: COMPARATOR
Intervention: Cellulose acetate mesh impregnated with essential fatty acids (Rayon®)
Number of subjects: 39
Study 32011356 — intervention group
Group type: EXPERIMENTAL
Intervention: Advocacy support for family caregivers
Number of subjects: 18
Study 32011356 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 18
Study 616191017 — intervention group
Group type: EXPERIMENTAL
Intervention: Luseogliflozin 2.5 mg once daily for the last 7 days
Number of subjects: 0
Study 616191017 — intervention group
Group type: COMPARATOR
Intervention: HC‐HGI (55% TEC and high GI)
Number of subjects: 0
Study 616191017 — intervention group
Group type: COMPARATOR
Intervention: HC‐LGI (55% TEC and low GI)
Number of subjects: 0
Study 616191017 — intervention group
Group type: EXPERIMENTAL
Intervention: LC‐HGI (40% TEC and high GI)
Number of subjects: 0
Study 34018672 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-day continuing professional development (CPD) education programme on the International Caries Classification and Management System (ICCMS™) and monthly performance feedback
Number of subjects: 14
Study 34018672 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 14
Study 33758968 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-nursing support
Number of subjects: 60
Study 33758968 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tele-nursing support)
Number of subjects: 60
Study 36093918 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 60
Study 36093918 — intervention group
Group type: COMPARATOR
Intervention: Esketamine (0.25 mg/kg)
Number of subjects: 60
Study 32369295 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 72
Study 32369295 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 72
Study 35977005 — intervention group
Group type: EXPERIMENTAL
Intervention: Brexpiprazole
Number of subjects: 727
Study 35977005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 727
Study 34392667 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 40
Study 32126317 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group exercise program (twice weekly for 12 weeks)
Number of subjects: 19
Study 36322381 — intervention group
Group type: EXPERIMENTAL
Intervention: Ortho-phosphoric acid (OPA)
Number of subjects: 96
Study 36322381 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-phosphoric acid (MPA)
Number of subjects: 96
Study 36322381 — intervention group
Group type: EXPERIMENTAL
Intervention: Application time of 15 seconds
Number of subjects: 96
Study 36322381 — intervention group
Group type: EXPERIMENTAL
Intervention: Application time of 7 seconds
Number of subjects: 96